Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to benefit child health.
Cure Kids Ventures is a vital part of Cure Kids’ vision of a healthy childhood for everyone.
Our team is skilled in early stage company development and have global experience in the biotech, healthcare and medical devices industry.
Cure Kids Ventures is a vital part of Cure Kids’ vision of a healthy childhood for everyone.
Our team is skilled in early stage company development and have global experience in the biotech, healthcare and medical devices industry.
Location: New Zealand, Auckland
Employees: 1-10
Phone:18247739
Founded date: 2008
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 19
| Date | Name | Website | Total Raised | Location |
| 23.02.2021 | Chitogel | chitogel.com | - | - |
| - | Microgem | zygem.com | - | - |
| - | AROA | aroabio.com | - | United Sta... |
| - | The a2 Mil... | thea2milkcompany.com | - | Australia,... |
| - | Noted Ltd | noted.com | - | New Zealan... |
| - | Objective ... | objectiveacuity.com | - | - |
| - | Adherium | adherium.com | $3M | New Zealan... |
| - | ableX Heal... | ablex.healthcare | - | New Zealan... |
| - | Chnnl | chnnl.app | - | New Zealan... |
| - | Avalia Imm... | avaliaimmunotherapies.com | - | - |
Show more
Mentions in press and media 3
| Date | Title | Description |
| 24.07.2026 | Wellumio Closes $9.75M to Commercialize Axana Portable Brain Imaging Device | What You Should Know New Zealand medical technology startup Wellumio has finalized its oversubscribed $9.75M pre-Series A funding round, adding international venture capital from Australia (Bioshore Ventures) and the United States (Jumpspac... |
| 08.07.2021 | $14m invested in world-leading RNA therapy: University of Otago spinout targeting new cancer treatments | Amaroq Therapeutics, a new biotech start-up spun out of the University of Otago, with one of the world’s most advanced programs in next-generation RNA therapy to target cancer has secured NZ$14m investment to accelerate development. |
| 28.05.2021 | The golden age of health-tech | Covid-19 has turned the world on its head, but it’s also sparked accelerated change in health-tech - and attracted a large amount of capital globally[1]. That mixed with an aging population, the need for personalised care, privacy, digitali... |